Mesenchymal stem cells overexpressing Sirt1 inhibit prostate cancer growth by recruiting natural killer cells and macrophages

Prostate cancer (PCa) has become the second leading cause of male cancer-related mortality in the United States. Mesenchymal stem cells (MSCs) are able to migrate to tumor tissues, and are thus considered to be novel antitumor carriers. However, due to their immunosuppressive nature, the application...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Yu, Yang, Zhang, Qingyun, Meng, Qinggui, Zong, Chen, Liang, Lei, Yang, Xue, Lin, Rui, Liu, Yan, Zhou, Yang, Zhang, Hongxiang, Hou, Xiaojuan, Han, Zhipeng, Cheng, Jiwen
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2016
Sujets:
Research Paper: Immunology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342066/
https://ncbi.nlm.nih.gov/pubmed/27764779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12737
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires